2,454 followers
Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy. #lymphoma #lymsm https://t.co/dJ1ApeYdj2
Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy. #lymphoma #lymsm https://t.co/dJ1ApeYdj2